Paediatrics

AMC Immunisation MCQs

This page explains the National Immunisation Program schedule, the contraindication rules and the pertussis decisions that AMC immunisation questions are built on. It flags the recent Australian changes overseas graduates often miss and finishes with original practice questions.

Most tested
What is due at each age, true versus false contraindications, live vaccine rules, pertussis in infants
Guideline to know
Australian Immunisation Handbook (digital edition) and the current NIP schedule
Classic trap
Delaying vaccines for a mild cold or egg allergy
Study time
5–6 hours

How immunisation is tested in the AMC MCQ exam

Immunisation questions are usually set in general practice or a child health clinic. A parent arrives for a scheduled vaccine, a child has missed doses, a pregnant woman asks what she needs, or a child has a reaction. The question asks which vaccines are due, whether a vaccine can be given today, what to do about a reaction, or how to manage a disease that vaccination prevents, most often pertussis.

The exam is written to the Australian Immunisation Handbook and the National Immunisation Program (NIP) schedule. These differ from UK and US schedules in timing, products and who is funded. Overseas graduates lose easy marks by answering from their home schedule. Learn the Australian schedule as it stands now, including recent changes.

A second theme is the difference between true contraindications and things that only look like contraindications. Most stems about a 'reason not to vaccinate' describe a false contraindication, and the best answer is to vaccinate today. Missed opportunities to vaccinate are a recurring exam message.

  • Know the schedule by age: birth, 6 weeks (from 6 weeks), 4 months, 6 months, 12 months, 18 months, 4 years, Year 7, Year 10, pregnancy.
  • Know which vaccines are live.
  • Know the funded extras for Aboriginal and Torres Strait Islander children and children with medical risk conditions.
  • Expect at least one pertussis vignette in a typical paediatric question set.

The NIP childhood schedule as it stands in late 2026

Birth: hepatitis B vaccine, ideally within 24 hours and certainly within 7 days. 2 months (can be given from 6 weeks): the hexavalent vaccine (DTPa-hepB-IPV-Hib), pneumococcal conjugate vaccine and oral rotavirus vaccine. 4 months: the same three again. 6 months: hexavalent vaccine, plus an extra pneumococcal dose for Aboriginal and Torres Strait Islander children and children with specified medical risk conditions.

12 months: MMR, meningococcal ACWY conjugate vaccine and pneumococcal conjugate vaccine. 18 months: DTPa, MMRV (measles-mumps-rubella-varicella) and Hib. 4 years: DTPa-IPV. Annual influenza vaccine is funded for all children aged 6 months to under 5 years, and for older children who are Aboriginal or Torres Strait Islander or have medical risk conditions. Children under 9 receiving influenza vaccine for the first time need two doses at least four weeks apart.

Recent changes matter. Since September 2025 the NIP childhood pneumococcal vaccine is a 20-valent conjugate vaccine (Prevenar 20), and older 13-valent and polysaccharide products were removed from the program in mid 2026. Meningococcal B vaccine is funded for Aboriginal and Torres Strait Islander infants and for children with certain medical conditions, and is recommended (but not funded nationally) for all infants. Some states fund wider MenB programs. Hepatitis A is funded for Aboriginal and Torres Strait Islander children in some jurisdictions. BCG is not routine in Australia and is reserved for specific groups, such as some Aboriginal and Torres Strait Islander newborns in high-incidence areas and children travelling to high-incidence countries.

School program: in Year 7, a single dose of 9-valent HPV vaccine and a dTpa booster. In Year 10, meningococcal ACWY. Catch-up HPV vaccination is funded for young people up to age 25. Pregnancy: influenza vaccine at any stage, dTpa in every pregnancy (ideally between 20 and 32 weeks), and the RSV vaccine Abrysvo from 28 weeks, funded under the NIP.

  • Live vaccines on the schedule: rotavirus (oral), MMR, MMRV, and BCG where used.
  • Pneumococcal for most children: 6 weeks, 4 months, 12 months. Extra 6-month dose for Aboriginal and Torres Strait Islander and at-risk children.
  • MMR at 12 months, MMRV at 18 months. MMRV is not used as the first measles-containing dose in children under 4 because of a higher risk of febrile seizures.
  • Rotavirus has strict upper age limits for each dose; doses given late are not given at all.
  • Year 7: HPV single dose plus dTpa. Year 10: MenACWY.

RSV protection for infants: maternal vaccine or nirsevimab

Australia now protects infants against RSV in two ways. The maternal RSV vaccine (Abrysvo) is funded through the NIP from 28 weeks of pregnancy and can be given at any time of year. Antibodies cross the placenta and protect the baby in early infancy.

The long-acting monoclonal antibody nirsevimab is offered through state and territory infant RSV programs rather than the NIP. It is recommended for infants under 8 months whose mother did not receive the RSV vaccine in pregnancy, infants born within two weeks of the maternal vaccine, and infants with conditions that increase their risk of severe RSV. Some children aged 8 to 24 months with risk conditions are recommended a dose before their second RSV season.

Exam logic: a baby whose mother had the maternal RSV vaccine more than two weeks before birth, and who has no risk condition, does not routinely need nirsevimab in the first six months. Nirsevimab is a passive antibody, not a vaccine, so it does not interfere with the routine schedule and can be given at the same visit as other vaccines.

  • Maternal RSV vaccine: from 28 weeks, funded under the NIP.
  • Nirsevimab: state and territory programs; check the local eligibility rules.
  • Maternal vaccine less than 2 weeks before birth: infant still recommended nirsevimab.

True and false contraindications

True contraindications are few. Anaphylaxis after a previous dose of the same vaccine, or to a component of the vaccine, is a contraindication to that vaccine. Live vaccines are contraindicated in pregnancy and in people with significant immunocompromise, including high-dose corticosteroid therapy, many chemotherapy regimens, biologic therapy and severe primary immunodeficiency. Rotavirus vaccine is contraindicated in infants with a history of intussusception or a congenital gut malformation that predisposes to it, and in severe combined immunodeficiency. Infants exposed to some biologic medicines in the womb may need live vaccines delayed; this is a specialist decision.

False contraindications appear far more often in stems. A mild illness with a temperature below 38.5 °C, a runny nose, being on antibiotics, a family history of a vaccine reaction, prematurity, breastfeeding, a pregnant mother at home, stable neurological conditions, eczema, a history of febrile seizure and egg allergy (including egg anaphylaxis) are not reasons to defer. Influenza vaccine and MMR can be given to children with egg allergy in a routine setting.

Timing rules: two live injectable vaccines that are not given on the same day should be separated by at least four weeks. MMR and varicella vaccines may need to be delayed after blood products or immunoglobulin, with the interval depending on the product. Inactivated vaccines can be given at any interval from each other. Preterm babies are vaccinated at the usual chronological age, not their corrected age, and some need extra doses (for example an additional hepatitis B dose or an extra pneumococcal dose in very preterm infants).

  • Anaphylaxis to a previous dose or component: true contraindication to that vaccine.
  • Live vaccine plus pregnancy or significant immunocompromise: contraindicated.
  • Egg allergy: not a contraindication to MMR or influenza vaccine.
  • Mild illness, antibiotics, prematurity, eczema, past febrile seizure: vaccinate today.
  • Preterm infants: vaccinate by chronological age.

Reactions, paracetamol and the Australian Immunisation Register

Common reactions include local pain, redness and swelling, low-grade fever and irritability. Large local reactions after the fourth or fifth DTPa dose are known and are not a contraindication to future doses. Fever after MMR or MMRV typically occurs about 7 to 12 days after vaccination, when the live virus replicates, and a mild rash may follow. Febrile seizures can occur, and a history of febrile seizure is not a contraindication to further vaccines.

Routine prophylactic paracetamol is not recommended with most vaccines because it may slightly reduce immune response and fever is usually mild. The exception is meningococcal B vaccine (Bexsero) in children under 2 years: the Handbook recommends prophylactic paracetamol with each dose, starting 30 minutes before or as soon as possible after the vaccine, because fever is common. This is an Australian-specific point that appears in exam questions.

Anaphylaxis after vaccination is rare and usually happens within 15 minutes, which is why everyone is observed for at least 15 minutes after vaccination. Treatment is intramuscular adrenaline into the anterolateral thigh. Vasovagal syncope is more common in adolescents, and they should be seated during vaccination.

All vaccines given in Australia are recorded on the Australian Immunisation Register (AIR). Being up to date on the AIR is linked to family payments (No Jab, No Pay) and, in several states, to childcare enrolment (No Jab, No Play). Conscientious objection is no longer an exemption for these payments. Serious or unexpected adverse events are reported to the state or territory health department or the TGA.

  • MenB in under-2s: prophylactic paracetamol with each dose.
  • Fever 7 to 12 days after MMR: expected viraemic reaction.
  • Observe for at least 15 minutes after vaccination.
  • Missed doses: use the Handbook catch-up calculator; never restart a schedule from the beginning.

Pertussis (whooping cough): what the exam wants

Pertussis is a key exam disease because it is most dangerous in infants too young to be fully vaccinated. Young infants may not whoop. They can present with apnoea, cyanotic episodes, coughing spasms followed by vomiting, or poor feeding, often with little fever. A very high lymphocyte count supports the diagnosis. Older children and adults present with a prolonged paroxysmal cough, a whoop on inspiration and post-tussive vomiting, and may feel well between paroxysms.

Diagnosis in the first three weeks of cough is by PCR on a nasopharyngeal swab. Serology is used later in the illness. Infants under six months, especially under three months, with suspected pertussis are usually admitted because of the risk of apnoea, pneumonia and death. Macrolide antibiotics (azithromycin is preferred in young infants) are given to reduce transmission; early treatment may shorten illness, but treatment late in the cough mainly prevents spread.

Pertussis is a notifiable disease in every Australian state and territory. Public health units advise on antibiotic prophylaxis for close contacts, with a focus on households that include young infants or women in late pregnancy. Children with pertussis are excluded from childcare and school until they have had five days of an appropriate antibiotic or until 21 days from the start of the cough, as set out in the NHMRC Staying Healthy guidance.

Prevention is the most heavily tested part. dTpa in every pregnancy, ideally between 20 and 32 weeks, gives the infant protective antibodies from birth. It is recommended in each pregnancy, even closely spaced ones. Infants should start their primary course on time, and the first dose can be given from 6 weeks of age. Adults who care for infants are recommended a booster if they have not had one in the past 10 years.

  • Young infant with apnoea and cough: think pertussis.
  • Cough under 3 weeks: nasopharyngeal PCR.
  • Treatment: azithromycin in infants; notify public health.
  • dTpa in every pregnancy, ideally 20 to 32 weeks.
  • Exclude until 5 days of antibiotics or 21 days from cough onset.

Australian differences and how to read immunisation stems

The Australian schedule differs from overseas schedules in several ways that the exam uses. The UK gives MenB to all infants on its routine schedule, while Australia funds it nationally only for Aboriginal and Torres Strait Islander infants and those with risk conditions. The UK gives BCG to selected infants and many countries give it to all; Australia does not give it routinely. Australia uses single-dose HPV in schools. Australia funds the maternal RSV vaccine nationally and nirsevimab through the states.

Read immunisation stems in this order. First, the child's age in weeks or months and whether they are Aboriginal or Torres Strait Islander or have a risk condition such as asplenia, prematurity or chronic disease. Second, the vaccine history: which doses have been given and when. Third, the reason the parent or nurse is hesitating. Most often the hesitation is a false contraindication, and the best answer is to vaccinate today and complete any catch-up.

When a parent is hesitant, the exam favours respectful, evidence-based discussion over refusal to treat or pressure. Acknowledge concerns, give clear information, and offer to vaccinate or to revisit. Do not discharge the family from the practice for declining vaccination.

  • Check identity and risk status: Aboriginal and Torres Strait Islander children get extra funded doses.
  • Check age limits: rotavirus has hard cut-offs.
  • Look for the hidden false contraindication.
  • Hesitant parent: listen, inform, offer, keep the door open.
Common immunisation scenarios and the expected answer
ScenarioCan you vaccinate today?Reason
Child with a runny nose and temperature 37.6 °CYesMinor illness is not a contraindication
Child with egg anaphylaxis due for MMRYes, routine settingMMR contains negligible egg protein
Infant with past intussusception due for rotavirusNo (rotavirus only)History of intussusception is a contraindication
Pregnant woman at 24 weeks asking about MMRNoLive vaccines are contraindicated in pregnancy; give after delivery
Preterm baby born at 30 weeks, now 8 weeks oldYesVaccinate by chronological age; may need extra doses
Child on high-dose prednisolone for several weeks due for MMRVDeferLive vaccine in significant immunosuppression
Infant of 12 weeks, mother had Abrysvo at 33 weeksRoutine vaccines yes; nirsevimab not routinely neededMaternal vaccine more than 2 weeks before birth protects the infant
Infant due MenB (Aboriginal child, 6 weeks)Yes, with prophylactic paracetamolFever is common with MenB in under-2s
Child with febrile seizure after last vaccinesYesPast febrile seizure is not a contraindication

Worked examples in AMC style

Pick an answer to see why each option is right or wrong. These examples are written for this page; the bank holds the full set for immunisation.

Example 1

A 4-month-old girl attends for her scheduled vaccines. Her mother says she has had a runny nose and mild cough for two days and is feeding normally. Her temperature is 37.7 °C and examination shows clear rhinorrhoea only. Her 2-month vaccines were given on time with no reaction.

What is the most appropriate next step?

Show answer and reasoning

Answer: B. Give all 4-month vaccines, including oral rotavirus, today

  • A. A mild upper respiratory illness without high fever is a false contraindication; deferring creates a missed opportunity.
  • B. Correct. Minor illness with a temperature below 38.5 °C is not a reason to delay. All due vaccines, including rotavirus within its age limit, should be given.
  • C. There is no reason to defer rotavirus, and delay risks passing the strict upper age limit for the dose.
  • D. Routine paracetamol before vaccination is not recommended (except with MenB in under-2s) and the fever is not significant.
  • E. Viral testing does not change the decision and delays protection.

Mild illness with temperature under 38.5 °C is not a contraindication. Vaccinate today.

Based on: Australian Immunisation Handbook: Preparing for vaccination

Example 2

A 6-week-old Aboriginal boy attends an Aboriginal Community Controlled Health Service for his first scheduled vaccines. He was born at term and is well. His mother asks whether he needs anything different from his cousin, who is not Aboriginal and was vaccinated at a clinic in another state last month.

In addition to the routine 6-week vaccines, which is most appropriate?

Show answer and reasoning

Answer: C. MenB vaccine with prophylactic paracetamol

  • A. BCG is reserved for specific groups such as newborns in some high-incidence areas, and a tuberculin test is not needed before BCG in a young infant.
  • B. Hepatitis A for Aboriginal and Torres Strait Islander children in some jurisdictions is given later in the second year, not at 6 weeks.
  • C. Correct. MenB is funded for Aboriginal and Torres Strait Islander infants from 6 weeks, and the Handbook recommends prophylactic paracetamol with each dose in under-2s.
  • D. A term infant who received the birth dose follows the routine hepatitis B schedule within the hexavalent vaccine.
  • E. Influenza vaccine starts from 6 months of age, not 6 weeks.

Aboriginal and Torres Strait Islander infants receive funded MenB from 6 weeks; give paracetamol with each MenB dose under 2 years.

Based on: Australian Immunisation Handbook: Meningococcal disease; NIP schedule

Example 3

A 7-week-old girl is brought to the emergency department after two episodes at home where she stopped breathing and turned blue during coughing spasms. She has had a cough for 10 days and vomits after coughing. She is afebrile. Her older brother has had a cough for a month. The mother did not receive any vaccines in pregnancy.

What is the most appropriate next step?

Show answer and reasoning

Answer: B. Admit, nasopharyngeal PCR swab and start azithromycin

  • A. A young infant with apnoea is at high risk of deterioration and should not be managed at home.
  • B. Correct. Apnoea with paroxysmal cough in an unvaccinated young infant with a coughing contact strongly suggests pertussis. Admit, confirm by PCR, treat with azithromycin and notify public health.
  • C. Serology is not the right test early in illness, and treatment should not wait.
  • D. Vaccination now will not treat the infection and does not protect quickly enough.
  • E. Bronchodilators do not help pertussis, and supportive care is only part of the plan.

Young infant with apnoea and coughing spasms: admit, PCR swab, azithromycin, notify.

Based on: Australian Immunisation Handbook: Pertussis; NHMRC Staying Healthy

Quick recall

Tap a card to turn it over. If you can answer all eight without looking, move on to timed questions.

Where candidates lose marks

  • Answering from your home schedule

    UK, US and other schedules differ in timing, products and funding. Use the Australian NIP and Handbook.

  • Deferring for a mild cold

    Minor illness with temperature under 38.5 °C is not a contraindication. Deferral creates a missed opportunity.

  • Using corrected age in preterm babies

    Preterm infants are vaccinated by chronological age, sometimes with extra doses.

  • Giving rotavirus late

    Rotavirus doses have upper age limits. If the window has passed, the dose is not given.

  • Forgetting the extras

    Aboriginal and Torres Strait Islander children are funded for MenB, an extra pneumococcal dose, influenza from 6 months and, in some jurisdictions, hepatitis A.

How to study immunisation

  1. Step 1: Write the NIP schedule from birth to Year 10 and pregnancy from memory, then check it against the current official schedule.

  2. Step 2: Mark which vaccines are live and add the extras for Aboriginal and Torres Strait Islander and at-risk children.

  3. Step 3: Read the Handbook pages on contraindications and make a two-column list of true and false contraindications.

  4. Step 4: Study RSV protection (maternal vaccine and nirsevimab) and the MenB paracetamol rule.

  5. Step 5: Pertussis: presentation in infants, PCR versus serology, azithromycin, notification and exclusion.

  6. Step 6: Do 25–30 immunisation MCQs and check every answer against the Handbook.

Practise immunisation free

Immunisation: questions candidates ask

Do I need to know vaccine brand names for the AMC exam?

Usually not. Know the vaccine type and age it is due, such as a 20-valent pneumococcal conjugate vaccine at 6 weeks, 4 months and 12 months. A brand name may appear in a stem, so recognising the main ones helps.

Has the Australian schedule changed recently?

Yes. Prevenar 20 replaced earlier pneumococcal vaccines in the childhood schedule from September 2025, the maternal RSV vaccine was added to the NIP in 2025, and older pneumococcal products left the program in mid 2026. Always check the current official schedule before your exam.

Is MenB vaccine given to all Australian infants?

It is recommended for all infants but funded nationally only for Aboriginal and Torres Strait Islander infants and children with certain medical conditions. Some states fund broader programs.

What is the most common immunisation exam question type?

Questions that describe a reason a parent or nurse wants to delay a vaccine. Most of these reasons are false contraindications, and the best answer is to vaccinate today.

Why is MMRV not given at 12 months?

Using MMRV as the first measles-containing dose in children under 4 years carries a higher risk of fever and febrile seizures. Australia gives MMR at 12 months and MMRV at 18 months.

Practise immunisation until the decisions are automatic

Free account, 50 questions, full explanations. Upgrade only if it helps.